|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0956 | ED149371 | General Research Use | No | Female | Black or African American | 57 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0974 | ED149965 | General Research Use | No | Male | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1437 | ED148803 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2088 | ED149308 | General Research Use | No | Female | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2218 | ED148365 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3037 | ED149838 | General Research Use | No | Male | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3832 | ED149445 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0630 | ED149206 | General Research Use | No | Male | White | 56 | 5 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0895 | ED149626 | General Research Use | No | Female | White | 58 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1079 | ED148737 | General Research Use | No | Female | White | 55 | 9 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2377 | ED149273 | General Research Use | No | Female | White | 59 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2510 | ED148210 | General Research Use | No | Female | White | 55 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3571 | ED149220 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3844 | ED149129 | General Research Use | No | Male | White | 59 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0364 | ED149794 | General Research Use | No | Male | White | 55 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1224 | ED148226 | General Research Use | No | Female | White | 59 | 10 - Central GA | 10 - Central GA |
| AR2_1421 | ED149815 | General Research Use | No | Female | White | 55 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2271 | ED148548 | General Research Use | No | Male | White | 58 | 5 - AREDS AMD Severity Scale Step 5 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3787 | ED148161 | General Research Use | No | Female | White | 56 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0274 | ED149668 | General Research Use | No | Female | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |